https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:32:092022-07-15 14:01:5920 years of real-world evidence data for fabry disease - Organised by SANOFI GENZYME
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:28:202022-07-15 14:02:05Hypertension treatment in special populations | Symposium 8.3
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:15:542022-07-15 14:03:01New aspects in AKI prevention and treatment | Symposium 9.4
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:09:572022-07-15 14:03:35Preeclampsia and kidney in 2021 | Symposium 2.3
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-08-30 10:25:002022-07-28 13:36:00A new approach for glomerulonephritis: targeting the alternative complement pathway - Organised by NOVARTIS PHARMA AG
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-08-30 10:19:532022-07-28 13:35:51Targeting CKD Patients' Quality of Life - Organised by FRESENIUS KABI
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:41:142022-07-28 13:35:42Renal denervation - a different tool for hypertension care - Organised by MEDTRONIC
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:40:062022-07-28 13:35:36Addressing gaps in patient care in rare inherited disorders: the role of the nephrologist - Organised by CHIESI FARMACEUTICI S.P.A.
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:38:572022-07-28 13:35:27A new perspective in the management of ATTP: the nephrologist approach - Organised by SANOFI GENZYME
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:37:582022-07-28 13:35:19Frontiers in the management of AHUS - Organised by ALEXION PHARMACUTICALS, INC.
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:36:562022-07-28 13:35:10Nonsteroidal MRAS to improve outcomes in patients with CKD and T2D - Organised by BAYER AG
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:34:442022-07-28 13:34:48Glycated albumin: a tool at clinicians’ hand in managing diabetic nephropathy - Organised by WERFEN AND ASAHI-KASEI PHARMA
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 15:33:312022-07-28 13:34:38GLP-1 receptor agonists and the kidney - Organised by NOVO NORDISK A/S
https://www.era-online.org/en/nep/wp-content/uploads/sites/9/2021/07/Logo-Virtual-58°-Congress_500.png500534ERAhttps://www.era-online.org/en/nep/wp-content/uploads/sites/9/2022/07/logo-nep.jpgERA2021-07-16 14:59:212022-07-28 13:36:20When delays could lead to ESKD. Identifying and managing primary hyperoxaluria in clinical practice - Organised by ALNYLAM PHARMACEUTICALS
20 years of real-world evidence data for fabry disease – Organised by SANOFI GENZYME
Hypertension treatment in special populations | Symposium 8.3
New treatment targets to halt CKD progression | Symposium 4.1
New nutritional targets in CKD | Symposium 4.6
COVID-19 in haemodialysis patients | Symposium 5.2
ANCA vasculitis prognostic and treatment | Symposium 3.6
Complicated lupus nephritis | Symposium 3.5
Late Breaking Clinical Trials | Symposium 0.1
Microbiome in CKD | Symposium 4.2
New aspects in AKI prevention and treatment | Symposium 9.4
Recent advances in kidney transplantation: focus on immunity | Symposium 7.2
Diabetic nephropathy in 2021 | Symposium 8.2
Onconephrology | Symposium 3.4
Preeclampsia and kidney in 2021 | Symposium 2.3
Future scenarios for renal disease | Symposium 0.6